Immobilization of Actively Thromboresistant Assemblies on Sterile Blood‐Contacting Surfaces

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Advanced Healthcare Materials

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1002/adhm.201300110PMID 23788402PMCID PMC3955951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein thioester synthesis enabled by sortase.

  2012cited by this paper
• Polymeric conjugates for drug delivery.

  2012cited by this paper
• The Use of Antithrombotic Therapies in Reducing Synthetic Small-Diameter Vascular Graft Thrombosis

  2012cited by this paper
• Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease.

  2012cited by this paper
• Nonhuman primate models of thrombosis.

  2012cited by this paper
• Thrombomodulin and its role in inflammation

  2011cited by this paper
• Radiation and Ethylene Oxide Terminal Sterilization Experiences with Drug Eluting Stent Products

  2011cited by this paper
• Nonthrombogenic approaches to cardiovascular bioengineering.

  2011cited by this paper
• A general strategy for the evolution of bond-forming enzymes using yeast display

  2011cited by this paper
• Making and breaking peptide bonds: protein engineering using sortase.

  2011cited by this paper
• An overview of tissue and whole organ decellularization processes.

  2011cited by this paper
• The Scandinavian Propaten(®) trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial.

  2011cited by this paper
• A Biologically Active Surface Enzyme Assembly that Attenuates Thrombus Formation

  2011cited by this paper
• Cu-free click cycloaddition reactions in chemical biology.

  2010cited by this paper
• Interface between hemostasis and adaptive immunity.

  2010cited by this paper
• Delivery of therapeutic proteins.

  2010cited by this paper
• Chemoselective immobilization of peptides on abiotic and cell surfaces at controlled densities.

  2010cited by this paper
• Sortase-mediated protein ligation: an emerging biotechnology tool for protein modification and immobilisation

  2009cited by this paper
• Sortase‐Mediated Ligation: A Gift from Gram‐Positive Bacteria to Protein Engineering

  2009cited by this paper
• Bioorthogonal chemistry: fishing for selectivity in a sea of functionality.

  2009cited by this paper
• Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts.

  2009cited by this paper
• Complexity in biomaterials for tissue engineering.

  2009cited by this paper
• Bioactivity and Platelet Adhesion Study of a Human Thrombomodulin-Immobilized Nitinol Surface

  2009cited by this paper
• Immobilization of heparin: approaches and applications.

  2008cited by this paper
• The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Biomimetic materials for tissue engineering.

  2008cited by this paper
• Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions.

  2008cited by this paper
• Mechanisms of thrombus formation.

  2008cited by this paper
• Modified Prosthetic Vascular Conduits

  2008cited by this paper
• Transient elastic support for vein grafts using a constricting microfibrillar polymer wrap.

  2008cited by this paper
• The catastrophe revisited: blood compatibility in the 21st Century.

  2007cited by this paper
• The effect of a recombinant elastin-mimetic coating of an ePTFE prosthesis on acute thrombogenicity in a baboon arteriovenous shunt.

  2007cited by this paper
• Heparan sulphate proteoglycans fine-tune mammalian physiology

  2007cited by this paper
• Novel thromboresistant materials.

  2007cited by this paper
• Ethylene oxide sterilization of medical devices: a review.

  2007cited by this paper
• Polymeric coatings that mimic the endothelium: combining nitric oxide release with surface-bound active thrombomodulin and heparin.

  2007cited by this paper
• Prosthetic vascular grafts: wrong models, wrong questions and no healing.

  2007cited by this paper
• Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results.

  2006cited by this paper
• Mechanistic investigation of the staudinger ligation.

  2005cited by this paper
• Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights Into Structure–Function Relationships and Molecular Recognition

  2005cited by this paper
• Staphylococcus aureus sortase transpeptidase SrtA: insight into the kinetic mechanism and evidence for a reverse protonation catalytic mechanism.

  2005cited by this paper
• Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro.

  2004cited by this paper
• C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity.

  2004cited by this paper
• Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.

  2004cited by this paper
• Expanding the Genetic Code

  2003cited by this paper
• Kinetic mechanism of Staphylococcus aureus sortase SrtA.

  2003cited by this paper
• Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates.

  2003cited by this paper
• Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

  2003cited by this paper
• Immobilization of human thrombomodulin to expanded polytetrafluoroethylene.

  2002cited by this paper
• Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex

  2000cited by this paper
• A review: taking the sterile out of sterility

  1999cited by this paper
• Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif.

  1999cited by this paper
• Blood flow and antithrombotic drug effects.

  1998cited by this paper
• Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates.

  1998cited by this paper
• The ideal small arterial substitute: a search for the Holy Grail?

  1998cited by this paper
• Microwave CO2 plasma-initiated vapour phase graft polymerization of acrylic acid onto polytetrafluoroethylene for immobilization of human thrombomodulin.

  1997cited by this paper
• Immobilization of human thrombomodulin onto PTFE

  1997cited by this paper
• Immobilization of human thrombomodulin onto biomaterials. Comparison of immobilization methods and evaluation of antithrombogenicity.

  1994cited by this paper
• Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

  1993cited by this paper
• Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.

  1991cited by this paper
• Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta

  1990cited by this paper
• The roles of protein C and thrombomodulin in the regulation of blood coagulation.

  1984cited by this paper
• Heparin Bonding on Colloidal Graphite Surfaces

  1963cited by this paper

• Application of Sortase‐Mediated Ligation for the Synthesis of Block Copolymers and Protein‐Polymer Conjugates

  2024cites this paper
• Covalent coating strategy for enhancing the biocompatibility and hemocompatibility of blood-contacting medical materials

  2022cites this paper
• L-DNA Oligonucleotide Exchange Enables the Replenishment of Coatings on Blood-Contacting Devices

  2022cites this paper
• A rechargeable anti-thrombotic coating for blood-contacting devices.

  2021cites this paper
• Regenerating Antithrombotic Surfaces through Nucleic Acid Displacement.

  2020cites this paper
• A dynamic remodeling bio-mimic extracellular matrix to reduce thrombotic and inflammatory complications of vascular implants.

  2020cites this paper
• Single and multi-functional coating strategies for enhancing the biocompatibility and tissue integration of blood-contacting medical implants.

  2020cites this paper
• Broadening the scope of sortagging

  2019cites this paper
• The blood compatibility challenge Part 4: Surface modification for hemocompatible materials: passive and active approaches to guide blood-material interactions.

  2019cites this paper
• Chapter 3 – Understanding and utilizing the biomolecule/nanosystems interface

  2018cites this paper
• Site-Specific Conjugation of Polymers to Proteins.

  2018cites this paper
• Thrombosis‐Responsive Thrombolytic Coating Based on Thrombin‐Degradable Tissue Plasminogen Activator (t‐PA) Nanocapsules

  2017cites this paper
• Application of modified yeast surface display technologies for non-Antibody protein engineering.

  2017cites this paper
• Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinations.

  2017cites this paper
• Animal models of cardiovascular disease as test beds of bioengineered vascular grafts.

  2017cites this paper
• Recent advances in covalent, site-specific protein immobilization

  2016cites this paper
• Biomolecular strategies to modulate the macrophage response to implanted materials.

  2016cites this paper
• Plasma Ion Activated Expanded Polytetrafluoroethylene Vascular Grafts with a Covalently Immobilized Recombinant Human Tropoelastin Coating Reducing Neointimal Hyperplasia.

  2016cites this paper
• Stent coatings for blood compatibility

  2016cites this paper
• Preparation of chain-end clickable recombinant protein and its bio-orthogonal modification.

  2016cites this paper
• In situ regeneration of bioactive coatings enabled by an evolved Staphylococcus aureus sortase A

  2016cites this paper
• Recent advances in covalent, site-specific protein immobilization [version 1; referees 3 approved

  2016cites this paper
• Immobilization of bioactive plasmin reduces the thrombogenicity of metal surfaces.

  2015cites this paper
• Enhancing the efficiency of sortase-mediated ligations through nickel-peptide complex formation.

  2015cites this paper
• Immunological and Phenotypic Considerations in Supplementing Cardiac Biomaterials with Cells

  2015cites this paper
• Synthesis and Characterization of Functionalized Recombinant Thrombomodulin for Antithrombotic Drug Development

  2015cites this paper
• Methods for the directed evolution of proteins

  2015cites this paper
• In vitro and ex vivo hemocompatibility of off-the-shelf modified poly(vinyl alcohol) vascular grafts.

  2015cites this paper
• Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue Factor

  2015cites this paper
• Biomaterials for Cardiac Regeneration

  2015cites this paper
• Flow-based enzymatic ligation by sortase A.

  2014cites this paper
• Engineering biomaterials surfaces to modulate the host response.

  2014cites this paper